Suven Life Sciences Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| SUVEN.NS | NBIX | I7G.F | SUPN | 0QFP.IL | ALKS | |
|---|---|---|---|---|---|---|
| Market cap | 78.02B | 16.81B | 12.79B | 1.64B | 4.46T | 7.71B |
| P/E (TTM) | — | 24.6 | 25.1 | — | 18.8 | — |
| Forward P/E | 14.3 | 13.9 | — | 6.3 | — | 25.4 |
| Price/book | 12.3 | 4.3 | 2.7 | -55.5 | 2.1 | 4.1 |
| Dividend yield | — | — | 1.05% | — | 7.74% | — |
| 1-year change | +43.18% | +7.27% | +24.26% | −11.32% | 0.00% | +44.85% |
| Today | 0.00% | +0.73% | +2.04% | +0.21% | +156.25% | +0.44% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All SUVEN.NS news ›Suven Life Sciences Ltd to Consider September Results on Nov 5
Suven Life Sciences Ltd will consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, at its November 5 board meeting. The scheduled review follows a consolidated net loss of Rs 127.61…
Suven Life Sciences Bags Two Patents
Drug firm Suven Life Sciences Ltd. has been granted one product patent each by Europe and Israel for a drug used in the treatment of neuro-degenerative diseases or an ailment which primarily affects the brain. In a BSE filing today, Suven…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- multibagg.ai1
- ndtvprofit.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.